Ra-223 Dichloride in mCRPC: More Is Not Better
Jun 19, 2018
A multicenter, international phase II study found higher-dose and extended-dose therapy with Ra-223 did not improve survival or pain scores.
Recent Content
Will a Trastuzumab Biosimilar Work in Early HER2+ Breast Cancer?
Jun 19, 2018
The trastuzumab biosimilar ABP 980 showed noninferiority to trastuzumab in a large trial of patients with early HER2-positive breast cancer.
Higher OS With Neoadjuvant Chemo-RT in Pancreatic Cancer
Jun 19, 2018
In PREOPANC, the 2-year survival rate was significantly higher for patients who received neoadjuvant chemoradiotherapy vs standard care.
Venetoclax Effective Against CLL in ‘Real-World’ Setting
Jun 19, 2018
Overall response was strong even in high-risk patients (over age 65, with 17p deletion, with prior ibrutinib therapy, and mutations of BTK and PLCγ2).
Venetoclax/Rituximab Combo Approved for CLL/SLL
Jun 18, 2018
FDA warns, however, about the possibility of TLS due to rapid tumor cell destruction.
Bevacizumab Rechallenge Benefit in Recurrent Ovarian Cancer?
Jun 18, 2018
New data suggest adding bevacizumab to chemotherapy may prolong PFS in patients with recurrent ovarian cancer.
Newer Targeted Agents in NSCLC: TAK-788, an EGFR and HER2 Inhibitor
Jun 18, 2018
Robert Doebele discusses TAK-788, a first-in-class inhibitor of both EGFR and HER2 shown in an early-phase study to be active in NSCLC.
Immunotherapy for Prostate Cancer: Where Do We Go From Here?—PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular Therapies
Jun 15, 2018
Here we focus on alternative methods of harnessing both adaptive and innate antitumor immunity to target prostate cancer cells, and look ahead to provide a perspective on how this growing collection of immunotherapeutic approaches may ultimately be combined to target prostate cancer from a variety of angles.
The Use of Surgery and Radiotherapy as Treatment of Regional Nodes in Breast Cancer Patients
Jun 15, 2018
This article discusses the ways in which pathologic regional nodal status affects clinical decisions about locoregional and systemic treatment, reviews published literature and guidelines, and aims to provide a practical perspective on treatment approach in the face of a broad range of data and recommendations.
Understanding the Benefits of Acupuncture Treatment for Cancer Pain Management
Jun 15, 2018
This article reviews how acupuncture is thought to work, data on acupuncture for managing pain caused by cancer or by cancer treatment, how acupuncture is practiced in the US medical system, discussion of safety issues, and practical tips on how to integrate acupuncture into cancer care.
